BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1513284)

  • 1. The synergism of gamma-interferon and tumor necrosis factor in whole body hyperthermia with vitamin C to control toxicity.
    Rosen P
    Med Hypotheses; 1992 Jul; 38(3):257-8. PubMed ID: 1513284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of recombinant human TNF and interferon-gamma in four patients with refractory AML.
    Fiedler W; Weh HJ; Hossfeld DK
    Eur J Haematol; 1992 Feb; 48(2):115-6. PubMed ID: 1547873
    [No Abstract]   [Full Text] [Related]  

  • 3. The synergism of gamma-interferon and tumor necrosis factor in whole body hyperthermia.
    Rosen P
    Med Hypotheses; 1990 Nov; 33(3):173-4. PubMed ID: 2127298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful whole body hyperthermia for cancer.
    Rosen P
    Med Hypotheses; 1989 May; 29(1):45-6. PubMed ID: 2747581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High plasma tumor necrosis factor (TNF)-alpha concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-alpha, interferon-gamma, and melphalan.
    Zwaveling JH; Maring JK; Clarke FL; van Ginkel RJ; Limburg PC; Hoekstra HJ; Koops HS; Girbes AR
    Crit Care Med; 1996 May; 24(5):765-70. PubMed ID: 8706451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal enhancement of both tumour necrosis factor alpha-induced systemic toxicity and tumour cure in rats.
    van der Zee J; van den Aardweg GJ; van Rhoon GC; van den Berg AP; de Wit R
    Br J Cancer; 1995 Jun; 71(6):1158-62. PubMed ID: 7779705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor and interferon gamma inhibit the development of radiation-induced thymic lymphomas in C57BL/Ka mice.
    Boniver J; Humblet C; Defresne MP
    Leukemia; 1989 Aug; 3(8):611-3. PubMed ID: 2501594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthermic enhancement of the antitumor effect of natural human tumor necrosis factor-alpha and -beta: an in vitro and in vivo study.
    Maeda T; Fuchimoto S; Orita K
    Jpn J Cancer Res; 1988 Sep; 79(9):1054-61. PubMed ID: 3142836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2.
    Aulitzky WE; Tilg H; Vogel W; Aulitzky W; Berger M; Gastl G; Herold M; Huber C
    Ann Hematol; 1991 Feb; 62(1):25-31. PubMed ID: 1903309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activity of recombinant mouse tumor necrosis factor (TNF) on colon cancer in rats is promoted by recombinant rat interferon gamma; toxicity is reduced by indomethacin.
    Marquet RL; Ijzermans JN; De Bruin RW; Fiers W; Jeekel J
    Int J Cancer; 1987 Oct; 40(4):550-3. PubMed ID: 3117712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional tumour necrosis factor combined with interferon gamma in metastatic melanoma.
    Retsas S; Leslie M; Bottomley D
    BMJ; 1989 May; 298(6683):1290-1. PubMed ID: 2500199
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
    Hori K; Ehrke MJ; Mace K; Mihich E
    Cancer Res; 1987 Nov; 47(22):5868-74. PubMed ID: 3117358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity.
    Young MR; Young ME; Wright MA
    Int J Cancer; 1990 Aug; 46(2):245-50. PubMed ID: 2143498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytopenia and complement activation under recombinant TNF alpha/IFN gamma therapy in man.
    Michelmann I; Böckmann D; Nürnberger W; Eckhof-Donovan S; Burdach S; Göbel U
    Ann Hematol; 1997 Apr; 74(4):179-84. PubMed ID: 9174546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined therapy of hyperthermia and tumor necrosis factor for nude mice bearing KK-47 bladder cancer.
    Amano T; Kumini K; Nakashima K; Uchibayashi T; Hisazumi H
    J Urol; 1990 Aug; 144(2 Pt 1):370-4. PubMed ID: 2374209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.
    de Kossodo S; Moore R; Gschmeissner S; East N; Upton C; Balkwill FR
    Br J Cancer; 1995 Nov; 72(5):1165-72. PubMed ID: 7577463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemotherapy for murine bladder tumor with a new human recombinant tumor necrosis factor (rTNF-S), VP-16 and hyperthermia.
    Iizumi T; Yazaki T; Waku M; Soma G
    J Urol; 1989 Aug; 142(2 Pt 1):386-9. PubMed ID: 2746758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human recombinant tumour necrosis factor and rat gamma interferon on nitrosomethylurea-induced mammary tumours.
    Shah P; van der Meide PH; Borman T; Schroeder N; Bliss JM; Coombes RC
    Br J Cancer; 1989 Feb; 59(2):206-9. PubMed ID: 2495016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of recombinant human tumour necrosis factor alpha and interferon gamma against surgically simulated wound infection in mice.
    Hershman MJ; Pietsch JD; Trachtenberg L; Mooney TH; Shields RE; Sonnenfeld G
    Br J Surg; 1989 Dec; 76(12):1282-6. PubMed ID: 2514003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthermia with simultaneous administration of interferon using established human renal carcinoma heterotransplanted in nude mice.
    Onishi T; Machida T; Mori Y; Iizuka N; Masuda F; Mochizuki S; Tsukamoto H; Harada N
    Br J Urol; 1989 Mar; 63(3):227-32. PubMed ID: 2495145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.